๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia

โœ Scribed by Rodeghiero, F. ;Castaman, G. ;Soffiati, G. ;Quaglio, R. ;Castronovo, S. ;Cortesi, S. ;Dini, E.

Publisher
Springer-Verlag
Year
1989
Weight
676 KB
Volume
59
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Acute lymphocytic leukemia: Biological m
Acute lymphocytic leukemia: Biological markers of clinical response
โœ Alvin M. Mauer; W. Paul Bowman; Lois W. Dow; A. Thomas Look; Dorothy Williams ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 512 KB

Treatment for acute lymphocytic leukemia (ALL) has been successful in producing cures for some children with that disease. It has become increasingly important therefore to develop treatment regimens for curable ALL that are effective for disease control but carry minimal risks of late detrimental c

Release and clinical significance of sol
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia
โœ B.D. Hock; L.J. Fernyhough; S.M. Gough; A. Steinkasserer; A.G. Cox; J.L. McKenzi ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 488 KB

Soluble CD83 (sCD83), a potent immunosuppressive agent, circulates at elevated levels in some chronic lymphocytic leukemia (CLL) patients. We report that CLL patients with elevated plasma sCD83 levels had significantly shorter (P=0.038) treatment free survival. Culture of CLL cells with solid phase